NSE · HCG · Healthcare
Healthcare Global Enterprises Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹350 Cr with net profit ₹2 Cr — a 0.44% net margin, versus -0.34% the period before.
Shareholding
As of 2026-06-30
- Promoter64.21%
- Public13.85%
- FII2.74%
- DII19.2%
48,905 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.56× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #16 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,802 Cr | 243.29 | 13.59 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,653 Cr | 317.16 | 10.11 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,940 Cr | 270.71 | 7.27 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,585 Cr | 189.09 | 9.39 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,328 Cr | 300.35 | 9.25 | 8.48% | 8.36% |
| Global Health Limited | ₹37,835 Cr | 262.54 | 9.54 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹31,901 Cr | 752.12 | 14.19 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,068 Cr | 235.79 | 12.38 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹17,029 Cr | 256.89 | 5.48 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,668 Cr | 395.44 | 7.73 | 6.58% | 6.4% |
| Healthcare Global Enterprises Ltd.(this company) | ₹10,132 Cr | 4524 | 7.61 | 0.03% | 0.54% |
AI analysis
AI-generated · google/gemini-2.5-flashHealthcare Global Enterprises Ltd. (HCG) has a market capitalization of Rs 9792 Cr. The company reported revenue of Rs 2257.66 Cr and diluted EPS of Rs 3.5. The promoter holding stands at 64.209% as of June 30, 2026.
Positives
- +Promoter holding is significant at 64.209% as of June 30, 2026.
- +Quarterly revenue has shown an increasing trend from Rs 558.57 Cr in Dec 2024 to Rs 652.33 Cr in Mar 2026.
- +Retail shareholder base expanded, with the number of shareholders increasing from 10,800 in Mar 2017 to 48,905 in June 2026.
Negatives
- −The company reported a negative net profit of -Rs 9.43 Cr in Dec 2025.
- −Promoter pledge stands at 5.17% of total promoter holding as of June 30, 2026.
- −The debt-to-equity ratio is relatively high at 1.78.
- −Return on Equity (ROE) is low at 3.7%.
- −Return on Capital Employed (ROCE) is low at 7.8114%.
Financial Performance
For the financial year ending March 2025, Healthcare Global Enterprises Ltd. reported revenue of Rs 2257.66 Cr and a net profit of Rs 44.41 Cr. Over the last four reported quarters, revenue increased from Rs 558.57 Cr in Dec 2024 to Rs 652.33 Cr in Mar 2026. However, net profit fluctuated, declining from Rs 6.98 Cr in Dec 2024 to -Rs 9.43 Cr in Dec 2025, before recovering to Rs 2.17 Cr in Mar 2026.
Profitability & Returns
The company’s Return on Equity (ROE) is 3.7% and Return on Capital Employed (ROCE) is 7.8114%, based on the latest available annual figures. The price-to-earnings (P/E) ratio stands at 168.67, with an EPS of Rs 3.5. The book value per share is Rs 66.16.
Balance Sheet
Healthcare Global Enterprises Ltd. has a debt-to-equity ratio of 1.78. No further details about the balance sheet, such as assets or liabilities breakdown, are available in the provided data.
Ownership & Pledges
A total of 5.17% of promoter holdings are pledged. Specifically, B S Ajaikumar has pledged 4,959,539 shares, representing 35.74% of their holding as of June 30, 2026.
Regulatory & Surveillance
No information regarding any regulatory actions or inclusion in surveillance lists is available for Healthcare Global Enterprises Ltd. in the provided data.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Healthcare Global Enterprises Ltd.share price & fundamentals